Price (delayed)
$40.02
Market cap
$8.9B
P/E Ratio
105.32
Dividend/share
$1.26
EPS
$0.38
Enterprise value
$9.62B
qiagen is the leading global provider of sample to insight solutions to transform biological materials into valuable molecular insights. qiagen sample technologies isolate and process dna, rna and proteins from
Special dividends are included in TTM DPS and yield
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from and Sharadar.